Family relations in the genomic era: Communicating about intergenerational transmission of risk for disability

Family Relations

Volumn 63, Issue 1, 2014, Pages 85-100

  Bailey, Donald B ^a,c   Lewis, Megan A ^a,c   Roche, Myra ^b,d   Powell, Cynthia M ^b,d  

^a RTI INTERNATIONAL   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c Departments of Pediatrics and Genetics ^*  (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Carrier; Disability; Families; Genetic testing

Indexed keywords

EID: 84892156015     PISSN: 01976664     EISSN: 17413729     Source Type: Journal    
DOI: 10.1111/fare.12054     Document Type: Article

References (104)

1. ACOG Committee on Genetics. (2010). ACOG committee opinion no. 469: Carrier screening for fragile X syndrome. Obstetrics & Gynecology, 116, 1008-1010.
2. Ahmed, S., Bekker, H., Hewison, J., & Kinsey, S. (2002). Thalassaemia carrier testing in Pakistani adults: Behaviour, knowledge and attitudes. Community Genetics, 5, 120-127.
3. American College of Medical Genetics. (2002). Genetics evaluation guidelines for the etiologic diagnosis of congenital hearing loss. Genetics in Medicine, 4, 162-171.
4. Andreasen, A. R. (1995). Marketing social change: Changing behavior to promote health, social development, and the environment. San Francisco, CA: Jossey-Bass.
5. Anido, A., Carlson, L. M., & Sherman, S. L. (2007). Attitudes toward fragile X mutation carrier testing from women identified in a general population survey. Journal of Genetic Counseling, 16, 97-104.
6. Archibald, A. D., Hickerton, C. L., Jaques, A. M., Wake, S., Cohen, J., & Metcalfe, S. A. (2013). "It's about having the choice": Stakeholder perceptions of population-based genetic carrier screening for fragile X syndrome. American Journal of Medical Genetics A, 161A, 48-58. doi:10.1002/ajmg.a.35674
7. Bailey, D. B., Bann, C., Bishop, E., Guarda, S., Barnum, L., & Roche, M. (2013). Can a decision aid enable informed decisions in neonatal nursery recruitment for a fragile X newborn screening study? Genetics in Medicine, 15, 299-306. doi:10.1038/gim.2012
8. Bailey, D. B., Bishop, E., Raspa, M., & Skinner, D. (2012). Caregiver opinions about fragile X population screening. Genetics in Medicine, 14, 115-121. doi:10.1038/gim.0b013e31822ebaa6
9. Bailey, D. B., Lewis, M. A., Harris, S. L., Grant, T., Bann, C., Bishop, E., ... Therrell, B. L. (2013). Design and evaluation of a decision aid for inviting parents to participate in a fragile X newborn screening pilot study. Journal of Genetic Counseling, 22, 108-117. doi:10.1007/s10897-012-9511-0
10. Bekker, H. L., Hewison, J., & Thornton, J. G. (2003). Understanding why decision aids work: Linking process with outcome. Patient Education and Counseling, 50, 323-329.
11. Bell, C. J., Dinwiddie, D. L., Miller, N. A., Hateley, S. L., Ganusova, E. E., Mudge, J., ... Kingsmore, S. F. (2011). Carrier testing for severe childhood recessive diseases by next-generation sequencing. Science Translational Medicine, 3, 1-14. doi:10.1126/scitranslmed.3001756
12. Berkman, N. D., DeWalt, D. A., Pignone, M. P., Sheridan, S. L., Lohr, K. N., Lux, L., ... Bonito, A. J. (2004). Literacy and health outcomes. Evidence report/technology assessment. No. 87 (AHRQ Publication No. 04-E007-2). Rockville, MD: Agency for Healthcare Research and Quality.
13. Borgo, G., Castellani, C., Bonizzato, A., Rolfini, R., Altieri, S., Zanolla, L., & Mastella, G. (1999). Carrier testing program in a high-risk cystic fibrosis population from northeastern Italy: Active recruitment of relatives via probands' parents. Community Genetics, 2(2/3), 82-90.
14. Borry, P., Fryns, J. P., Schotsmans, P., & Dierickx, K. (2005). Attitudes towards carrier testing in minors: A systematic review. Genetic Counseling, 16, 341-352.
15. Bosworth, H. B., Olsen, M. K., Gentry, P., Orr, M., Dudley, T., McCant, F., & Oddone, E. Z. (2005). Nurse administered telephone intervention for blood pressure control: A patient-tailored multifactorial intervention. Patient Education and Counseling, 57, 5-14.
16. Cambiaghi, S., Restano, L., Paakkonen, K., Caputo, R., & Kere, J. (2000). Clinical findings in mosaic carriers of hypohidrotic ectodermal dysplasia. Archives of Dermatology, 136, 217-224.
17. Centers for Disease Control and Prevention. (n.d.). Hearing loss in children data and statistics. Retrieved from http://www.cdc.gov/ncbddd/hearingloss/data.html
18. Charles, C., Gafni, A., & Whelan, T. (1999). Decision-making in the physician-patient encounter: Revisiting the shared treatment decision-making model. Social Science & Medicine, 49, 651-661.
19. Cho, D., McGowan, M. L., Metcalfe, J., & Sharp, R. R. (2013). Expanded carrier screening in reproductive healthcare: Perspectives from genetics professionals. Human Reproduction, 28, 1725-1730. doi:10.1093/humrep/det091
20. Coffee, B., Keith, K., Albizua, I., Malone, T., Mowrey, J., Sherman, S. L., & Warren, S. T. (2009). Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. American Journal of Human Genetics, 85, 503-514. doi:10.1016/j.ajhg.2009.09.007
21. Cross-Disorder Group of the Psychiatric Genomics Consortium, Lee, S. H., Ripke, S., Neale, B. M., Faraone, S. V., Purcell, S. M., ... Wray, N. R. (2013). Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs. Nature Genetics, 45, 984-994. doi:10.1038/ng.2711
22. Devlin, B., & Scherer, S. W. (2012). Genetic architecture in autism spectrum disorder. Current Opinion in Genetics & Development, 22, 229-237. doi:10.1016/j.gde.2012.03.002
23. Dudbridge, F. (2013). Power and predictive accuracy of polygenic risk scores. PLoS Genetics, 9(3), 1-17. doi:10.1371/journal.pgen.1003348
24. Elwyn, G., Frosch, D., Volandes, A. E., Edwards, A., & Montori, V. M. (2010). Investing in deliberation: A definition and classification of decision support interventions for people facing difficult health decisions. Medical Decision Making, 30, 701-711. doi:10.1177/0272989X10386231
25. Fahmy, M. S. (2011). On the supposed moral harm of selecting for deafness. Bioethics, 25(3), 128-136. doi:10.1111/j.1467-8519.2009.01752.x
26. Fanos, J. H., Davis, J., & Puck, J. M. (2001). Sib understanding of genetics and attitudes toward carrier testing for X-linked severe combined immunodeficiency. American Journal of Medical Genetics, 98, 46-56.
27. Fanos, J. H., & Johnson, J. P. (1995). Barriers to carrier testing for adult cystic fibrosis sibs: The importance of not knowing. American Journal of Medical Genetics, 59, 85-91.
28. Gershon, E. S., & Alliey-Rodriguez, N. (2013). New ethical issues for genetic counseling in common mental disorders. American Journal of Psychiatry, 170, 968-976. doi:10.1176/appi.ajp.2013.12121558
29. Goldsmith, L., Jackson, L., O'Connor, A., & Skirton, H. (2013). Direct-to-consumer genomic testing from the perspective of the health professional: A systematic review of the literature. Journal of Community Genetics, 4, 169-180. doi:10.1007/s12687-012-0135-8
30. Gollust, S. E., Thompson, R. E., Gooding, H. C., & Biesecker, B. B. (2003). Living with achondroplasia: Attitudes toward population screening and correlation with quality of life. Prenatal Diagnosis, 23, 1003-1008.
31. Grody, W. W., Thompson, B. H., Gregg, A. R., Bean, L. H., Monaghan, K. G., Schneider, A., & Lebo, R. V. (2013). ACMG position statement on prenatal/preconception expanded carrier screening, Genetics in Medicine, 15, 482-483.
32. Grønborg, T. K., Schendel, D. E., & Parner, E. T. (2013). Recurrence of autism spectrum disorders in full- and half-siblings and trends over time: A population-based cohort study. JAMA Pediatrics, 167, 947-953. doi:10.1001/jamapediatrics.2013.2259
33. Haga, S. B., Barry, W. T., Mills, R., Ginsburg, G. S., Svetkey, L., Sullivan, J., & Willard, H. F. (2013). Public knowledge of and attitudes toward genetics and genetic testing. Genetic Testing and Molecular Biomarkers, 17, 327-335.
34. Hamshere, M. L., Langley, K., Martin, J., Agha, S. S., Stergiakouli, E., Anney, R. J., ... Thapar, A. (2013). High loading of polygenic risk for ADHD in children with comorbid aggression. American Journal of Psychiatry, 170, 909-916. doi:10.1176/appi.ajp.2013.12081129
35. Henneman, L., Bramsen, I., Van Os, T. A., Reuling, I. E., Heyerman, H. G., van der Laag, J., ... ten Kate, L. P. (2001). Attitudes towards reproductive issues and carrier testing among adult patients and parents of children with cystic fibrosis (CF). Prenatal Diagnosis, 21, 1-9.
36. Hereditary Hearing Loss. (n.d.). Introduction. Retrieved from http://hereditaryhearingloss.org/main.aspx?c=HHH&n=86163
37. Hilgert, N., Smith, R. J., & Van Camp, G. (2009). Function and expression pattern of nonsyndromic deafness genes. Current Molecular Medicine, 9, 546-564.
38. Hoogerwaard, E. M., van der Wouw, P. A., Wilde, A. A., Bakker, E., Ippel, P. F., Oosterwijk, J. C., ... de Visser, M. (1999). Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscular Disorders, 9, 347-351.
39. Huguet, G., Ey, E., & Bourgeron, T. (2013). The genetic landscapes of autism spectrum disorders. Annual Review of Genomics and Human Genetics, 14, 191-213. doi:10.1146/annurev-genom-091212-153431
40. Hurle, B., Citrin, T., Jenkins, J. F., Kaphingst, K. A., Lamb, N., Roseman, J. E., & Bonham, V. L. (2013). What does it mean to be genomically literate? National Human Genome Research Institute meeting report. Genetics in Medicine, 15, 658-663.
41. Ioannou, L., Massie, J., Collins, V., McClaren, B., & Delatycki, M. B. (2010). Population-based genetic screening for cystic fibrosis: Attitudes and outcomes. Public Health Genomics, 13, 449-456. doi:10.1159/000276544
42. James, C. A., Holtzman, N. A., & Hadley, D. W. (2003). Perceptions of reproductive risk and carrier testing among adolescent sisters of males with chronic granulomatous disease. American Journal of Medical Genetics: Part C, Seminars in Medical Genetics, 119C, 60-69.
43. Jans, S. M., Henneman, L., de Jonge, A., van El, C. G., van Tuyl, L. H., Cornel, M. C., & Lagro-Janssen, A. L. (2013). 'A morass of considerations': Exploring attitudes towards ethnicity based haemoglobinopathy-carrier screening in primary care. Family Practice, 30, 604-610.
44. Jensen, J. D., King, A. J., Carcioppolo, N., & Davis, L. (2012). Why are tailored message more effective? A multiple mediation analysis of breast cancer screening intervention. Journal of Communication, 62, 851-868. doi:10.1111/j.1460-2466.2012.01668.x
45. Jerant, A., Kravitz, R. L., Rooney, M., Amerson, S., Kreuter, M. W., & Franks, P. (2007). Effects of a tailored multimedia computer program on determinants of colorectal cancer screening: A randomized controlled pilot study in physician offices. Patient Education and Counseling, 66, 67-74.
46. Kalf, R. R., Mihaescu, R., Kundu, S., de Knijff, P., Green, R. C., & Janssens, A. C. (2013). Variations in predicted risks in personal genome testing for common complex diseases. Genetics in Medicine. Advance online publication. doi:10.1038/gim.2013.80
47. Kaphingst, K. A., McBride, C. M., Wade, C., Alford, S. H., Reid, R., Larson, E., ... Brody, L. C. (2012). Patients' understanding of and responses to multiplex genetic susceptibility test results. Genetics in Medicine, 14, 681-687.
48. Kingsmore, S. (2012, May 2). Comprehensive carrier screening and molecular diagnostic testing for recessive childhood diseases. PloS Currents, e4f9877ab8ffa9. doi:10.1371/4f9877ab8ffa9
49. Kreuter, M., Farrell, D., Olevitch, L., & Brennan, L. (2000). Tailoring health messages: Customizing communication with computer technology. Mahwah, NJ: Lawrence Erlbaum.
50. Kreuter, M. W., & Wray, R. J. (2003). Tailored and targeted health communication: Strategies for enhancing information relevance. American Journal of Health Behavior, 27, S227-S232.
51. Lachance, C. R., Erby, L. A., Ford, B. M., Allen, V. C., Jr., & Kaphingst, K. A. (2010). Information content, literacy demands, and usability of websites offering health-related genetic tests directly to consumers. Genetics in Medicine, 12, 304-312. doi:10.1097/GIM.0b013e3181dbd8b2
52. Lea, D. H., Kaphingst, K. A., Bowen, D., Lipkus, I., & Hadley, D. W. (2011). Communicating genetic and genomic information: Health literacy and numeracy considerations. Public Health Genomics, 14, 279-289. doi:10.1159/000294191
53. Lefebvre, R. C. (2013). Social marketing and social change: Strategies and tools for improving health, well-being, and the environment. San Francisco, CA: Jossey-Bass.
54. Locock, L., & Kai, J. (2008). Parents' experiences of universal screening for haemoglobin disorders: Implications for practice in a new genetics era. British Journal of General Practice, 58(548), 161-168. doi:10.3399/bjgp08X277276
55. Mand, C., Duncan, R. E., Gilliam, L., Collins, V., & Delatycki, M. B. (2009). Genetic selection for deafness: The views of hearing children of deaf adults. Journal of Medical Ethics, 35, 722-728. doi:10.1136/jme.2009.030429
56. Maxwell, S. J., Kyne, G., Molster, C., Barker, N. M., Ormsby, J., & O'Leary, P. (2011). Perceptions of population cystic fibrosis prenatal and preconception carrier screening among individuals with cystic fibrosis and their family members. Genetic Testing and Molecular Biomarkers, 15(3), 159-164. doi:10.1089/gtmb.2010.0121
57. McBride, C. M., Bastian, L. A., Halabi, S., Fish, L., Lipkus, I. M., Bosworth, H. B., ... Siegler, I. C. (2002). A tailored intervention to aid decision-making about hormone replacement therapy. American Journal of Public Health, 92, 1112-1114.
58. McBride, C. M., Wade, C. H., & Kaphingst, K. A. (2010). Consumers' views of direct-to-consumer genetic information. Annual Review of Genomics and Human Genetics, 11, 427-446. doi:10.1146/annurev-genom-082509-141604
59. McClaren, B. J., Aitken, M., Massie, J., Amor, D., Ukoumunne, O. C., & Metcalfe, S. A. (2013). Cascade carrier testing after a child is diagnosed with cystic fibrosis through newborn screening: Investigating why most relatives do not have testing. Genetics in Medicine, 15, 533-540. doi:10.1038/gim.2012.175
60. McClaren, B. J., Metcalfe, S. A., Aitken, M., Massie, R. J., Ukoumunne. O. C., & Amor, D. J. (2010). Uptake of carrier testing in families after cystic fibrosis diagnosis through newborn screening. European Journal of Human Genetics, 18, 1084-1089. doi:10.1038/ejhg.2010.78
61. McConkie-Rosell, A., Spiridigliozzi, G. A., Iafolla, T., Tarleton, J., & Lachiewicz, A. M. (1997). Carrier testing in the fragile X syndrome: Attitudes and opinions of obligate carriers. American Journal of Medical Genetics, 68, 62-69.
62. McConkie-Rosell, A., Spiridigliozzi, G. A., Rounds, K., Dawson, D. V., Sullivan, J. A., ... Lachiewicz, A. M. (1999). Parental attitudes regarding carrier testing in children at risk for fragile X syndrome. American Journal of Medical Genetics, 82, 206-211.
63. McConkie-Rosell, A., Spiridigliozzi, G. A., Sullivan, J. A., Dawson, D. V., & Lachiewicz, A. M. (2002). Carrier testing in fragile X syndrome: When to tell and test. American Journal of Medical Genetics, 110, 36-44.
64. McGowan, M. L., Cho, D., & Sharp, R. (2013). The changing landscape of carrier screening: Expanding technology and options? Health Matrix, 23, 15-33.
65. Morton, C. C., & Nance, W. E. (2006). Newborn hearing screening-A silent revolution. New England Journal of Medicine, 354, 2151-2164.
66. National Institute on Deafness and Other Communication Disorders. (2013). Quick statistics. Retrieved from http://www.nidcd.nih.gov/health/statistics/Pages/quick.aspx
67. Nelson, D. L., Orr, H. T., & Warren, S. T. (2013). The unstable repeats-Three evolving faces of neurological disease. Neuron, 77, 825-843. doi:10.1016/j.neuron.2013.02.022
68. Noar, S. M., Benac, C. N., & Harris, M. S. (2007). Does tailoring matter? Meta-analytic review of tailored print health behavior change interventions. Psychological Bulletin, 133, 673-693.
69. Nolin, S. L., Sah, S., Glicksman, A., Sherman, S. L., Allen, E., Berry-Kravis, E., ... Hadd, A. G. (2013). Fragile X AGG analysis provides new risk predictions for 45-69 repeat alleles. American Journal of Medical Genetics Part A, 161, 771-778. doi:10.1002/ajmg.a.35833
70. O'Connor, A. M., Bennett, C. L., Stacey, D., Barry, M., Col, N. F., Eden, K. B., ... Rovner, D. (2009). Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews, 3, CD001431. doi:10.1002/14651858.CD001431.pub2
71. Paasche-Orlow, M. K., & Wolf, M. S. (2010). Promoting health literacy research to reduce health disparities. Journal of Health Communication, 15(S2), 34-41.
72. Paul, D. B. (2008). Patient advocacy in newborn screening: Continuities and discontinuities. American Journal of Medical Genetics Part C (Seminars in Medical Genetics), 148C, 8-14. doi:10.1002/ajmg.c.30166
73. Persico, A. M., & Napolioni, V. (2013). Autism genetics. Behavioural Brain Research, 251, 95-112. doi:10.1016/j.bbr.2013.06.012
74. Pirozzi, F., Tabolacci, E., & Neri, G. (2011). The FRAXopathies: Definition, overview, and update. American Journal of Medical Genetics Part A, 155, 1803-1816. doi:10.1002/ajmg.a.34113
75. Plug, I., Mauser-Bunschoten, E. P., Brocker-Vriends, A. H., van Amstel, H. K., van der Bom, J. G., van Diemen-Homan, J. E., ... Rosendaal, F. R. (2006). Bleeding in carriers of hemophilia. Blood, 108(1), 52-56.
76. Poot, M. (2013). Towards identification of individual etiologies by resolving genomic and biological conundrums in patients with autism spectrum disorders. Molecular Syndromology, 4, 213-226. doi:10.1159/000350041
77. Pray, J. L., & Jordon, I. K. (2010). The deaf community and culture at a crossroads: Issues and challenges. Journal of Social Work Disability and Rehabilitation, 9, 168-193. doi:10.1080/1536710X.2010.493486
78. Raabe, F. J., & Spengler, D. (2013). Epigenetic risk factors in PTSD and depression. Front Psychiatry, 4, 1-17. doi:10.3389/fpsyt.2013.00080
79. Renwick, A., Thompson, D., Seal, S., Kelly, P., Chagtai, T., Ahmed, M., ... Rahman, N. (2006). ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nature Genetics, 38, 873-875.
80. Ross, L. F. (2012). A re-examination of the use of ethnicity in prenatal carrier testing. American Journal of Medical Genetics Part A, 158A, 19-23.
81. Ross, L. F., Saal, H. M, David, K. L., Anderson, R. R., American Academy of Pediatrics, American College of Medical Genetics and Genomics. (2013). Technical report: Ethical and policy issues in genetic testing and screening of children, Genetics in Medicine, 15, 234-245.
82. Rossi, J., Newschaffer, C., & Yudell, M. (2013). Autism spectrum disorders, risk communication, and the problem of inadvertent harm. Kennedy Institute of Ethics Journal, 23, 105-138.
83. Salm, M., Abbate, K., Appelbaum, P., Ottman, R., Chung, W., Marder, K., ... Klitzman, R. (2013). Use of genetic tests among neurologists and psychiatrists: Knowledge, attitudes, behaviors, and needs for training. Journal of Genetic Counseling. Advance online publication.
84. Shaw, A., & Hurst. J. A. (2009). 'I don't see any point in telling them': Attitudes to sharing genetic information in the family and carrier testing of relatives among British Pakistani adults referred to a genetics clinic. Ethnicity & Health, 14, 205-224. doi:10.1080/13557850802071140
85. Shearer, A. E., Black-Ziegelbein, E. A., Hildebrand, M. S., Eppsteiner, R. W., Ravi, H., Joshi, S., ... Smith, R. J. (2013). Advancing genetic testing for deafness with genomic technology. Journal of Medical Genetics, 50, 627-634. doi:10.1136/jmedgenet-2013-101749
86. Skinner, D., Sparkman, K. L., & Bailey, D. B. (2003). Screening for fragile X syndrome: Parent attitudes and perspectives. Genetics in Medicine, 5, 378-384.
87. Smith, R. J. H., Sheffield, A. M., & Van Camp, G. (2013) Deafness and hereditary hearing loss overview. In P. A. Pagon, M. P. Adam, T. D. Bird, C. R. Dolan, C. T. Fong, & S. Stephens (Eds.), GeneReviews™ [Internet]. Seattle: University of Washington.
88. Solomon, A. (2012). Far from the tree: Parents, children, and the search for identity. New York: Scribner.
89. Sorenson, J. R., Lakon, C., Spinney, T., & Jennings-Grant, T. (2004). Assessment of a decision aid to assist genetic testing research participants in the informed consent process. Genetic Testing, 8, 336-346.
90. Sorenson, P. L., Gane, L. W., Yarborough, M., Hagerman, R., & Tassone, F. (2013). Newborn screening and cascade testing for FMR1 mutations. American Journal of Medical Genetics Part A, 161A, 59-69.
91. Sullivan, S. D., Welt, C., & Sherman, S. (2011). FMR1 and the continuum of primary ovarian insufficiency. Seminars in Reproductive Medicine, 29, 299-307. doi:10.1055/s-0031-1280915
92. Supic, G., Jagodic, M., & Magic, Z. (2013). Epigenetics: A new link between nutrition and cancer. Nutrition and Cancer, 65, 781-792. doi:10.1080/01635581.2013.805794
93. Swift, M., Reitnauer, P. J., Morrell, D., & Chase, C. L. (1987). Breast and other cancers in families with ataxia-telangiectasia. New England Journal of Medicine, 316, 1289-1294.
94. Syurina, E. V., Brankovic, I., Probst-Hensch, N., & Grand, A. (2011). Genome-based health literacy: A new challenge for public health genomics. Public Health Genomics, 14, 201-210.
95. Tassone, F., & Hagerman, R. (2012). The fragile X-associated tremor ataxia syndrome. Results and Problems in Cell Differentiation, 54, 337-357. doi:10.1007/978-3-642-21649-7_18
96. Tassone, F., Long, K., Tong, T., Lo, J., Gane, L., Berry-Kravis, E., ... Hagerman, R. (2012). FMR1 CGG allele size and prevalence ascertained through newborn screening in the United States. Genome Medicine, 4(12), 1-13.
97. Theilade, J., Kanters, J., Henriksen, F. L., Gilsa-Hansen, M., Svendsen, J. H., Eschen, O., ... Bundgaard, H. (2013). Cascade screening in families with inherited cardiac diseases driven by cardiologists: Feasibility and nationwide outcome in Long QT syndrome. Cardiology, 126, 131-137.
98. Thoonen, B. P., Schermer, T. R, Jansen, M., Smeele, I., Jacobs, A. J., Grol, R., & van Schayck, O. C. (2002). Asthma education tailored to individual patient needs can optimise partnerships in asthma self-management. Patient Education and Counseling, 47, 355-360.
99. Turk, J. (2011). Fragile X syndrome: Lifespan developmental implications for those without as well as with intellectual disability. Current Opinion in Psychiatry, 24, 387-397. doi:10.1097/YCO.0b013e328349bb77
100. Vassoler, F. M., & Sadri-Vakili, G. (2013). Mechanisms of transgenerational inheritance of addictive-like behaviors. Neuroscience. Advance online publication. doi:10.1016/j.neuroscience.2013.07.064. Retrieved from http://dx.doi.org/10.1016/j.neuroscience.2013.07.064
101. Wade, C. H., Wilfond, B. S., & McBride, C. M. (2010). Effects of genetic risk information on children's psychosocial wellbeing: A systematic review of the literature. Genetics in Medicine, 12, 317-326. doi:10.1097/GIM.0b013e3181de695c
102. Wasson, K., Sanders, T. N., Hogan, N. S., Cherny, S., & Helzlsouer, K. J. (2013). Primary care patients' views and decisions about, experience of and reactions to direct-to-consumer genetic testing: A longitudinal study. Journal of Community Genetics, 4, 495-505.
103. Watson, E. K., Mayall, E. S., Lamb, J., Chapple, J., & Williamson, R. (1992). Psychological and social consequences of community carrier screening programme for cystic fibrosis. Lancet, 340, 217-220.
104. Wehbe, R. M., Spiridigliozzi, G. A., Heise, E. M., Dawson, D. V., & McConkie-Rosell, A. (2009). When to tell and test for genetic carrier status: Perspectives of adolescents and young adults from fragile X families. American Journal of Medical Genetics Part A, 149A, 1190-1199. doi:10.1002/ajmg.a.32840